Having signed recent deals with two other top
cancer-focused companies, ImmunoGen announces collaboration with Novartis for rights to use TAP Technology
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.